Sigma Healthcare Limited announced that against a backdrop of entering the final stage of investment cycle, progressively stabilising and optimising operations, and a strategic review of the business, Sigma is not providing specific guidance for 2023 at this stage, but expects to return to profit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.235 AUD | -1.98% | -2.76% | +22.89% |
05-10 | Sigma Healthcare Limited(ASX:SIG) added to S&P/ASX 200 Index | CI |
05-02 | Boral to Exit S&P/ASX 200 Index Following Takeover Bid | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.89% | 1.3B | |
+21.93% | 73.38B | |
-1.71% | 24.13B | |
+7.33% | 8.78B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B |
- Stock Market
- Equities
- SIG Stock
- News Sigma Healthcare Limited
- Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023